Document is current

Any future updates will be listed below

Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)

Crossref DOI link: https://doi.org/10.1007/s10549-022-06613-4

Published Online: 2022-05-04

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark